Publications by authors named "Jonathan W Uhr"

Claim this Profile
T
The clinical potential of circulating tumor cells; the need to incorporate a modern "immunological cocktail" in the assay.
Jonathan W Uhr

Cancers (Basel)· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system.
Yu-Yen Huang, Kazunori Hoshino, Peng Chen, Chun-Hsien Wu, Nancy Lane, Jonathan W Uhr

Biomed Microdevices· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the enumeration and phenotyping of CTC.
Frank A W Coumans, Sjoerd T Ligthart, Jonathan W Uhr, Leon W M M Terstappen

Clin Cancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of individual tumor cells by hyperspectral microscopic imaging.
Jonathan W Uhr, Michael L Huebschman, Eugene P Frenkel, Nancy L Lane, Raheela Ashfaq

Transl Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microchip-based immunomagnetic detection of circulating tumor cells.
Kazunori Hoshino, Yu-Yen Huang, Nancy Lane, Michael Huebschman, Jonathan W Uhr

Lab Chip· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversies in clinical cancer dormancy.
Jonathan W Uhr, Klaus Pantel

Proc Natl Acad Sci U S A· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Handheld histology-equivalent sectioning laser-scanning confocal optical microscope for interventional imaging.
Karthik Kumar, Rony Avritscher, Youmin Wang, Nancy Lane, David C Madoff, Jonathan W Uhr

Biomed Microdevices· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate.
Rosalia Rabinovsky, Jonathan W Uhr, Ellen S Vitetta, Eitan Yefenof

Adv Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer diagnostics: one-stop shop.
Jonathan W Uhr

Nature· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mathematical models of cancer dormancy.
Karen Page, Jonathan W Uhr

Leuk Lymphoma· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells in patients with breast cancer dormancy.
Songdong Meng, Debasish Tripathy, Eugene P Frenkel, Sanjay Shete, Elizabeth Z Naftalis, Jonathan W Uhr

Clin Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells.
Radu Marches, Jonathan W Uhr

Int J Cancer· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.
W Jeffrey Allard, Jeri Matera, M Craig Miller, Madeline Repollet, Mark C Connelly, Jonathan W Uhr

Clin Cancer Res· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes.
Robert C Hsueh, Adrienne M Hammill, Jamie A Lee, Jonathan W Uhr, Richard H Scheuermann

BMC Immunol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis